Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).

Willem A. Kamps(Pediatric Oncology Group), A van der Does-van den Berg(Universität Hamburg), Martin Schrappe(University Hospital Schleswig-Holstein), R Släter, K. Hählen, H. Riehm, Lou A. Smets, Elisabeth R. van Wering(Stichting Kinderoncologie Nederland), J.F. van der Weerden(Stichting Kinderoncologie Nederland), E. van den Berg-de Ruiter, Ron S. Weening, J Hermans(Leiden University Medical Center), G. A. M. de Vaan, J.P.M. Bökkerink, Helmut Gadner(Olgahospital)
PubMed
August 15, 1999
Cited by 107

Related Papers

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
|Blood|2008|607